|
1
|
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.
|
J Am Coll Cardiol
|
1991
|
6.55
|
|
2
|
How should results from completed studies influence ongoing clinical trials? The CAFA Study experience.
|
Ann Intern Med
|
1991
|
2.06
|
|
3
|
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.
|
Am Heart J
|
2006
|
1.24
|
|
4
|
Two cell lines from bone marrow that differ in terms of collagen synthesis, osteogenic characteristics, and matrix mineralization.
|
J Bone Joint Surg Am
|
1993
|
1.23
|
|
5
|
Polymethylmethacrylate-induced inflammatory macrophages resorb bone.
|
J Bone Joint Surg Br
|
1992
|
1.11
|
|
6
|
Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells.
|
Ann Rheum Dis
|
1996
|
0.97
|
|
7
|
Intermittent and continuous cocaine administration: residual behavioral states during withdrawal.
|
Pharmacol Biochem Behav
|
1992
|
0.89
|
|
8
|
Pluripotential mesenchymal cells repopulate bone marrow and retain osteogenic properties.
|
Clin Orthop Relat Res
|
2000
|
0.87
|
|
9
|
Anatomical effects of periosteal elevation.
|
J Orthop Res
|
2000
|
0.82
|
|
10
|
Temporospatial fate of bacteria and immune effector expression in house flies fed GFP-Escherichia coli O157:H7.
|
Med Vet Entomol
|
2014
|
0.81
|
|
11
|
Continuous or intermittent cocaine administration: effects of amantadine treatment during withdrawal.
|
Pharmacol Biochem Behav
|
1994
|
0.79
|
|
12
|
Cerebral microembolism in acute myocardial infarction.
|
Stroke
|
1999
|
0.78
|
|
13
|
Aortic root trauma: serious injuries requiring early recognition and management.
|
J Trauma
|
2000
|
0.78
|
|
14
|
Withdrawal from continuous or intermittent cocaine: effects of NAN-190 on cocaine-induced locomotion.
|
Pharmacol Biochem Behav
|
1993
|
0.77
|
|
15
|
Continuous or intermittent cocaine administration: effects of flupenthixol treatment during withdrawal.
|
Pharmacol Biochem Behav
|
1994
|
0.76
|
|
16
|
Is colour flow imaging needed to exclude clinically significant valvular regurgitation in adult patients undergoing transthoracic echocardiography?
|
Can J Cardiol
|
1997
|
0.75
|